LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1

Journal of Lipid Research

Volumn 45, Issue 5, 2004, Pages 972-980

  Wang, Yutong ^a   Kurdi Haidar, Buran ^b   Oram, John F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

ATP binding cassette transporter A1; Coenzyme A; Liver X receptor

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ACYL COENZYME A DESATURASE; APOLIPOPROTEIN; CYCLIC AMP DERIVATIVE; GENE PRODUCT; HIGH DENSITY LIPOPROTEIN; LIGAND; LINOLEIC ACID; LIVER X RECEPTOR; MONOUNSATURATED FATTY ACID; PALMITIC ACID; RETINOID X RECEPTOR; SATURATED FATTY ACID; STEARIC ACID; TROGLITAZONE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONJUGATION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; FATTY ACID DESATURATION; GENE INDUCTION; GENETIC TRANSCRIPTION; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN STABILITY; RECEPTOR UPREGULATION; RISK ASSESSMENT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CALPAIN; CELL LINE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FATTY ACIDS, UNSATURATED; LINOLEIC ACID; MACROPHAGES; MICE; PALMITATES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STEAROYL-COA DESATURASE;

EID: 2142756699     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400011-JLR200     Document Type: Article

References (46)

1. Oram, J. F. 2003. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler. Thromb. Vasc. Biol. 23: 720-727.
2. Wang, N., and A. R. Tall. 2003. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23: 1178-1184.
3. Singaraja, R. R., L. R. Brunham, H. Visscher, J. J. Kastelein, and M. R. Hayden. 2003. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler. Thromb. Vasc. Biol. 23: 1322-1332.
4. Wellington, C. L., L. R. Brunham, S. Zhou, R. R. Singaraja, H. Visscher, A. Gelfer, C. Ross, E. James, G. Liu, M. T. Huber, Y. Z. Yang, R. J. Parks, A. Groen, J. Fruchart-Najib, and M. R. Hayden. 2003. Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1. J. Lipid Res. 44: 1470-1480.
5. Assman, G., A. von Eckardstein, and H. B. Brewer. 1995. Familial high density lipoprotein deficiency: Tangier disease. In The Metabolic and Molecular Bases of Inherited Disease, C. R. Scriver et al., editors. McGraw-Hill, New York. 2053-2072.
6. Serfaty-Lacrosniere, C., F. Civeira, A. Lanzberg, P. Isaia, J. Berg, E. D. Janus, M. P. Smith, Jr., P. H. Pritchard, J. Frohlich, R. S. Lees, G. F. Barnard, J. M. Ordovas, and E.J. Schaefer. 1994. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis. 107: 85-98.
7. Clee, S. M., J. J. Kastelein, M. van Dam, M. Marcil, K. Roomp, K. Y. Zwarts, J. A. Collins, R. Roelants, N. Tamasawa, T. Stulc, T. Suda, R. Ceska, B. Boucher, C. Rondeau, C. DeSouich, A. Brooks-Wilson, H. O. Molhuizen, J. Frohlich, J. Genest, Jr., and M. R. Hayden. 2000. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J. Clin. Invest. 106: 1263-1270.
8. Joyce, C., L. Freeman, H. B. Brewer, Jr., and S. Santamarina-Fojo. 2003. Study of ABCA1 function in transgenic mice. Arterioscler. Thromb. Vasc. Biol. 23: 965-971.
9. Aiello, R. J., D. Brees, and O. L. Francone. 2003. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler. Thromb. Vasc. Biol. 23: 972-980.
10. Lawn, R. M., D. P. Wade, M. R. Garvin, X. Wang, K. Schwartz, J. G. Porter, J. J. Seilhamer, A. M. Vaughan, and J. F. Oram. 1999. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104: R25-R31.
11. Langmann, T., J. Klucken, M. Reil, G. Liebisch, M. F. Luciani, G. Chimini, W. E. Kaminski, and G. Schmitz. 1999. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257: 29-33.
12. Schwartz, K., R. M. Lawn, and D. P. Wade. 2000. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem. Biophys. Res. Commun. 274: 794-802.
13. Costet, P., Y. Luo, N. Wang, and A. R. Tall. 2000. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275: 28240-28245.
14. Repa, J. J., and D. J. Mangelsdorf. 1999. Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr. Opin. Biotechnol. 10: 557-563.
15. Oram, J. F., R. M. Lawn, M. R. Garvin, and D. P. Wade. 2000. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275: 34508-34511.
16. Bortnick, A. E., G. H. Rothblat, G. Stoudt, K. L. Hoppe, L. J. Royer, J. McNeish, and O. L. Francone. 2000. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275: 28634-28640.
17. Repa, J. J., G. Liang, J. Ou, Y. Bashmakov, J. M. Lobaccaro, I. Shimomura, B. Shan, M. S. Brown, J. L. Goldstein, and D. J. Mangelsdorf. 2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14: 2819-2830.
18. Schultz, J. R., H. Tu, A. Luk, J. J. Repa, J. C. Medina, L. Li, S. Schwendner, S. Wang, M. Thoolen, D. J. Mangelsdorf, K. D. Lustig, and B. Shan. 2000. Role of LXRs in control of lipogenesis. Genes Dev. 14: 2831-2838.
19. Chisholm, J. W., J. Hong, S. A. Mills, and R. M. Lawn. 2003. The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J. Lipid Res. 44: 2039-2048
20. Wellington, C. L., E. K. Walker, A. Suarez, A. Kwok, N. Bissada, R. Singaraja, Y. Z. Yang, L. H. Zhang, E. James, J. E. Wilson, O. Francone, B. M. McManus, and M. R. Hayden. 2002. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab. Invest. 82: 273-283.
21. Kakko, S., J. Kelloniemi, P. von Rohr, I. Hoeschele, M. Tamminen, M. E. Brousseau, Y. A. Kesaniemi, and M. J. Savolainen. 2003. ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease. Atherosclerosis. 166: 285-290.
22. Hovingh, G. K., M. J. Van Wijland, A. Brownlie, R. J. Bisoendial, M. R. Hayden, J. J. Kastelein, and A. K. Groen. 2003. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia. J. Lipid Res. 44: 1251-1255.
23. Woll, P. S., N. Q. Hanson, and M. Y. Tsai. 2003. Absence of ABCA1 mutations in individuals with low serum HDL-cholesterol. Clin. Chem. 49: 521-522.
24. Wang, Y., and J. F. Oram. 2002. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J. Biol. Chem. 277: 5692-5697.
25. Ntambi, J. M., and M. Miyazaki. 2003. Recent insights into stearoyl-CoA desaturase-1. Curr. Opin. Lipidol. 14: 255-261.
26. Sun, Y., M. Hao, Y. Luo, C. P. Liang, D. L. Silver, C. Cheng, F. R. Maxfield, and A. R. Tall. 2003. Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure. J. Biol. Chem. 278: 5813-5820.
27. Murthy, S., E. Born, S. N. Mathur, and F. J. Field. 2004. LXR-mediated increase in ABCA1 expression is attenuated by fatty acids in CaCo2 cells: effect on cholesterol efflux to HDL. Biochem. J. 377: 545-552.
28. Mendez, A. J., J. F. Oram, and E. L. Bierman. 1991. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J. Biol. Chem. 266: 10104-10111.
29. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337.
30. Park, Y., J. M. Storkson, J. M. Ntambi, M. E. Cook, C. J. Sih, and M. W. Pariza. 2000. Inhibition of hepatic stearoyl-CoA desaturase activity by trans-10,cis-12 conjugated linoleic acid and its derivatives. Biochim. Biophys. Acta. 1486: 285-292.
31. Lee, K. N., M. W. Pariza, and J. M. Ntambi. 1998. Conjugated linoleic acid decreases hepatic stearoyl-CoA desaturase mRNA expression. Biochem. Biophys. Res. Commun. 248: 817-821.
32. Choi, Y., Y. C. Kim, Y. B. Han, Y. Park, M. W. Pariza, and J. M. Ntambi. 2000. The trans-10,cis-12 isomer of conjugated linoleic acid downregulates stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes. J. Nutr. 130: 1920-1924.
33. Choi, Y., Y. Park, M. W. Pariza, and J. M. Ntambi. 2001. Regulation of stearoyl-CoA desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells. Biochem. Biophys. Res. Commun. 284: 689-693.
34. Choi, Y., Y. Park, J. M. Storkson, M. W. Pariza, and J. M. Ntambi. 2002. Inhibition of stearoyl-CoA desaturase activity by the cis-9,trans-11 isomer and the trans-10,cis-12 isomer of conjugated linoleic acid in MDA-MB-231 and MCF-7 human breast cancer cells. Biochem. Biophys. Res. Commun. 294: 785-790.
35. Kurebayashi, S., T. Hirose, Y. Miyashita, S. Kasayama, and T. Kishimoto. 1997. Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes. Diabetes. 46: 2115-2118.
36. Kim, Y. C., F. E. Gomez, B. G. Fox, and J. M. Ntambi. 2000. Differential regulation of the stearoyl-CoA desaturase genes by thiazolidinediones in 3T3-L1 adipocytes. J. Lipid Res. 41: 1310-1316.
37. Arakawa, R., and S. Yokoyama. 2002. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J. Biol. Chem. 277: 22426-22429.
38. Wang, N., W. Chen, P. Linsel-Nitschke, L. O. Martinez, B. Agerholm-Larsen, D. L. Silver, and A. R. Tall. 2003. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J. Clin. Invest. 111: 99-107.
39. Martinez, L. O., B. Agerholm-Larsen, N. Wang, W. Chen, and A. R. Tall. 2003. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J. Biol. Chem. 278: 37368-37374.
40. Feng, B., and I. Tabas. 2002. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J. Biol. Chem. 277: 43271-43280.
41. Ou J., H. Tu, B. Shan, A. Luk, R. A. DeBose-Boyd, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 2001. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA. 98: 6027-6032.
42. Uehara, Y., T. Engel, Z. Li, C. Goepfert, S. Rust, X. Zhou, C. Langer, C. Schachtrup, J. Wiekowski, S. Lorkowski, G. Assmann, and A. Von Eckardstein. 2002. Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes. 51: 2922-2928.
43. Bierman, E. L. 1992. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler. Thromb. 12: 647-656.
44. Ginsberg, H. N. 1991. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care. 14: 839-855.
45. Zheng, Y., K. J. Eilertsen, L. Ge, L. Zhang, J. P. Sundberg, S. M. Prouty, K. S. Stenn, and S. Parimoo. 1999. Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat. Genet. 23: 268-270.
46. Miyazaki, M., Y. C. Kim, M. P. Gray-Keller, A. D. Attie, and J. M. Ntambi. 2000. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J. Biol. Chem. 275: 30132-30138.